Literature DB >> 8245182

Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.

R G Cowan1, G B Winnie.   

Abstract

To explore possible mechanisms for the association between elevated immunoglobulin levels and lower pulmonary function in cystic fibrosis patients, we measured serum IgG subclass levels and anti-P. aeruginosa IgG subclass titers and correlated levels with neutrophil phagocytosis and chemotaxis. Serum was obtained from 13 cystic fibrosis patients colonized with the same serotype of P. aeruginosa, 12 noncolonized patients, and 12 normal volunteers. All anti-P. aeruginosa IgG subclass titers were elevated in serum from colonized patients. IgG3 level and anti-P. aeruginosa IgG3 titer were inversely correlated with pulmonary function. Phagocytosis of P. aeruginosa by neutrophils correlated with serum IgG3 level and was increased by opsonization with serum from colonized patients. Chemotactic index was increased in serum from colonized patients and inversely correlated with pulmonary function chest roentgenogram score. Chemotactic index directly correlated with anti-P. aeruginosa IgG3 titer and serum IgG3. These data demonstrate that cystic fibrosis patients with increased IgG3 levels are in poorer clinical condition and that their serum enhances neutrophil function. Such patients may have increased pulmonary inflammation with subsequent lung damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245182     DOI: 10.1007/bf00920245

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  36 in total

1.  Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  R B Fick; J Olchowski; S U Squier; W W Merrill; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1986-03

Review 2.  Human IgG subclass measurements in the clinical laboratory.

Authors:  R G Hamilton
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

3.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

4.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 5.  Immunologic aspects of cystic fibrosis.

Authors:  G Döring; A Albus; N Høiby
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

6.  Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection.

Authors:  G B Winnie; J D Klinger; J M Sherman; M J Thomassen
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection.

Authors:  T Pressler; S S Pedersen; F Espersen; N Høiby; C Koch
Journal:  Pediatr Pulmonol       Date:  1992-09

8.  Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.

Authors:  M Pollack
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

9.  Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.

Authors:  U B Schaad; A B Lang; J Wedgwood; A Ruedeberg; J U Que; E Fürer; S J Cryz
Journal:  Lancet       Date:  1991-11-16       Impact factor: 202.731

10.  Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.

Authors:  A Albus; M Saalmann; H Tesch; S S Pedersen; G Döring
Journal:  APMIS       Date:  1989-12       Impact factor: 3.428

View more
  2 in total

1.  IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.

Authors:  Patricia J Dubin; Jay K Kolls
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-27       Impact factor: 5.464

2.  FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia.

Authors:  Lawrence M Rhein; Michael Perkins; Norma P Gerard; Craig Gerard
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-01       Impact factor: 6.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.